4-HO-MET: Difference between revisions
From Pharmacopedia
More actions
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) Category taxonomy ship: retag Research Materials -> Research chemicals |
MDElliottMD (talk | contribs) home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean) |
||
| Line 21: | Line 21: | ||
| indications = | | indications = | ||
| dosing = | | dosing = | ||
<titration slug="erowid-dose-oral" author="erowid-claude" | |||
title="Oral dose ladder (Erowid)"> | |||
Erowid's dosage documentation for oral 4-HO-MET<ref name="erowid-4homet-dose"> | |||
Erowid. 4-HO-MET Dosage. Erowid.org. | |||
https://www.erowid.org/chemicals/4_ho_met/4_ho_met_dose.shtml. | |||
Accessed 2026-05-25.</ref> reports the following tiers: | |||
* '''Threshold:''' 2-8 mg | |||
* '''Light:''' 5-10 mg | |||
* '''Common:''' 8-15 mg | |||
* '''Strong:''' 10-20 mg | |||
* '''Heavy:''' 25+ mg | |||
Insufflated doses are reported in a similar range (threshold 2-7 mg, | |||
light 5-10 mg, common 8-15 mg, strong 12-20 mg, heavy 20+ mg); onset | |||
via insufflation is more abrupt and duration shorter than oral route. | |||
Onset and duration data are not specified by Erowid for this substance. | |||
</titration> | |||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | | interactions = <pharmaInteractions/> | ||